Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.